期刊文献+

胱抑素C与高血压颈动脉IMT的关系研究 被引量:6

Correlation between Cystatin C and Carotid Intima-media Thickness in Patients with Hypertension
原文传递
导出
摘要 目的探讨胱抑素C(Cys C)与原发性高血压患者颈动脉内膜-中层厚度(IMT)的关系。方法选择138例原发性高血压患者,检测患者血清Cys C、生化及血压指标;应用彩色多普勒超声检查仪测定颈动脉IMT,按照颈动脉IMT将原发性高血压患者分为IMT正常组和IMT增厚组,对两组血清Cys C、生化、年龄及血压指标进行比较,并分析上述指标与颈动脉IMT的关系。结果原发性高血压患者IMT增厚组血清Cys C明显高于IMT正常组[(1.32±0.42)vs(1.11±0.28)mg/L](t=2.69,P<0.05)。Spearman相关分析发现颈动脉IMT与血清Cys C、年龄显著相关(r=0.398,P<0.01;r=0.512,P<0.01),多元逐步回归分析显示Cys C并非颈动脉IMT的独立危险因素;在调整年龄进行偏相关分析显示Cys C与IMT的相关性差异无统计学意义(r=0.047,P>0.05)。结论血清Cys C与原发性高血压颈动脉IMT无确切关联,不能作为其预测指标。 Objective To investigate the correlation between serum cystatin C and carotid intima-media thickness(IMT) in patients with essential hypertension.Methods One hundred and thirty eight patients with essential hypertension were divided into normal group and abnormal group according to Carotid IMT measured by Doppler ultrasonography;and the serum cystatin C,biochemical indicator and the blood pressure of both groups were detected and compared simultaneously.Results Serum cystatin C levels in abnormal group were higher than that in normal group[(1.32±0.42) vs(1.11±0.28) mg/L](t=2.69,P0.05).On spearman correlation analysis showed that carotid IMT was positively correlated to serum cystatin C and age(r=0.398,P0.01;r=0.512,P0.01).The multiple linear regression analysis showed that cystatin C was not the independent risk factor for carotid IMT.After adjustment for age,partial correlation analysis showed that there was no independent association between serum cystatin C level and carotid IMT(r=0.047,P0.05).Conclusion There is no definite correlation between serum cystatin C and carotid IMT in patients with essential hypertension,and serum cystatin C cannot serve as the indicators for carotid IMT.
出处 《中华全科医学》 2012年第2期211-212,共2页 Chinese Journal of General Practice
关键词 胱抑素C 高血压 颈动脉内膜中层厚度 Cystatin C Hypertension Carotid intima-media thickness
  • 相关文献

参考文献11

  • 1Dhamidharka VR, Kwon G, Stevens G. Serum cystatin C is superior to serum creatinine as a marker of kidney function : a recta-analysis [ J ]. Am J Kidney Dis,2002,40(2) :221-226.
  • 2Roos JF, Doust J, Tctt SE, et al. Diagnostic accuracy of cystafin C com- pared to serum creatinine for the estimetion of renal dysfunction in a- dults and ehildren-a recta-analysis[ J]. Clin Biochem,2007,40(5-6) : 383-391.
  • 3李莉,刘凌云,赵元明,万丹.测定血清胱抑素C在肾脏疾病中的诊断价值[J].中华全科医学,2011,9(3):457-458. 被引量:25
  • 4Sanae W,Takafumi O,Jun L,et al end-organ damage in patients with tens Res,2003,26( 11 ) :895-899.
  • 5Serum cystatin C level is a mark of essential hypertension [ J ]. Hyper- Arpeg,4rd J, Ostergren J, de Faire U, et al. Cystatin C a marker of peripheral atherosclerotic disease? [ J ]. Atherosclerosis, 2008, 199 (2) :397-401.
  • 6Koenig W, TwardelIa D, Brenner H, et al. Plasma concentrations of cys- tatin C in patients with coronary heart disease and risk for secondary cardiovascular events:more than simply a marker of glomeralar filtra- tion rate[ J]. Clin Chem,2005,51 (2) :321-327.
  • 7Rodondi N,Yerly P,Gabriel A,et al. Microalbuminuria,but not cysta- tin C, is associated with carotid atherosclerosls in middle-aged adults [ J ]. Nephrol Dial Transplant ,2007,22 ( 4 ) : 1107-1114.
  • 8Anh LB, R.onit K, Bryan K, et al. Cystatin C and carotid intima-media thickness in asymptomatic adults : the Multi-Ethnic Study of Atheroscle- rosis (MESA) [ J ]. AJKD ,2009,53 ( 3 ), :389-398.
  • 9Joachim HI, Michael CS, Glenn MC,et al. Association of cystatin C with mortality, cardiovascular events, and incident heart failure among persons with coronary heart disease: data from the Heart and Soul Study [ J]. Circulation. 2007.115 ( 2 ) : 173-179.
  • 10Groesbeck D, Kottgen A, Parekh R, et al. Age, gender, and race effects on levels in US adolescents [ J ]. Clin J Am soc Nephrol, 2008,3 (6) : 1777-1785.

二级参考文献9

共引文献24

同被引文献55

  • 1孙建琦,胡宇宁,汪靖,章锡林,胡剑平.胱抑素C与原发性高血压患者室壁厚度及心功能不全的相关性[J].安徽医学,2013,34(10):1478-1480. 被引量:11
  • 2卢曙芳,沈建国,朱麒钱,官莉莉.2型糖尿病患者颈动脉内膜中层厚度与细胞间黏附分子1、C反应蛋白的相关性[J].中华内分泌代谢杂志,2006,22(4):358-359. 被引量:20
  • 3Ogawa Y,Goto T,Tamasawa N,et al. Serum cystatin C in di- abetic patients. Not only an indicator for renal dysfunction in patients with overt nephropathy but also a predictor for car- diovascular events in patients without nephropathy [ J ]. Dia- betes Res Clin Pract ,2008 ,79 (2) : 357 - 361.
  • 4Keevil BG, Kilpatrick ES, Nichols SP, et al. Biological varia- tion of cystatin C :implications for the assessment of glomeru- lar filtration rate[J]. Clin Chem 1998,44(7) :1 535 - 1 539.
  • 5Arpeg:rd J, Ostergren J, de Faire U, el al. Cystatin C--a marker of peripheral atherosclerotic disease? [ J ]. Athero- sclerosis, 2008,199 (2) : 397 - 401.
  • 6Keller T,Messow CM,Lubos E,et al. Cystafin C and cardio- vascular morality in patients with coronary artery disease and normal or mildly reduced kidney function: results from the AtheroGene study[J]. Eur Heart J,2009,30(3) :314- 320.
  • 7Bui AL,Katz R,Kestenbaum B,et al. Cystatin C and carotid intima-media thickness in asymptomatie adults:the Multi- Ethnic Study of Atherosclerosis (MESA) [ J ]. Am J Kidney Dis ,2009,53 (3) :389 - 398.
  • 8Niccoli G, Conte M, Della Bona R, et al. Cystatin C is asso- ciated with an increased coronary atherosclerotic burden and a stable plaque phenoltype in patients with ischemic heart disease and normal glomerular filtration rate [ J ]. Atheroscle- rosis,2008,198(2) :373 -380.
  • 9S.tevens LA, Schmid CH, Greene T, et al. Factors other than glomerular filtration rate affect serum cystatin C levels [ J ]. Kidney Int,2009,75(6) :652-660.
  • 10ChewJS, Saleem M, Florkowski CM, et a1. Cystatin C-a paradigm of evidence based laboratory medicine. Clin Biochem Rev, 2008, 29 :47-62.

引证文献6

二级引证文献41

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部